Anoop Sheshadri, MD (2016-2017)

While completing his renal fellowship at the University of California, San Francisco, Dr. Sheshadri was awarded the American Kidney Fund Clinical Scientist in Nephrology Fellowship. His fellowship was funded by Amgen and Sanofi Renal. Dr. Sheshadri’s research was titled Pedometers and Exercise in Dialysis. Aims of his research included determining whether a pedometer-based walking intervention would result in increased physical activity in patients treated with dialysis, and whether increased physical activity in patients treated with dialysis would result in improved physical function and in endothelial function. Currently, Dr. Sheshadri sees patients at the Nephrology and Hypertension Faculty Practice at the UCSF Medical Center, where he is also a Clinical Instructor.

Megan Yanik, MD (2016-2017)

When awarded the American Kidney Fund Clinical Scientist in Nephrology Fellowship, a program funded by Amgen and Sanofi Renal, Dr. Yanik was also in the process of completing her fellowship in pediatric nephrology at the University of Alabama at Birmingham. Dr. Yanik’s research was to determine the influence the CYP3A5 genotype has on the time to achieve a therapeutic level of tacrolimus in pediatric kidney transplant recipients, and to determine the influence of CYP3A5 genotype on risk for acute rejection episodes in pediatric kidney transplant recipients. Dr. Yanik is currently, Assistant Professor and Pediatric Nephrologist at Children’s Hospital of Alabama – Nephrology.

John Stanifer, MD, MSc (2015-2017)

As the American Kidney Fund-Amgen Clinical Scientist in Nephrology fellow, as well as a fellow at Duke University’s Department of Medicine, Division of Nephrology, Dr. Stanifer’s research aimed to assess the health literacy of individuals with chronic kidney disease from an underserved community in southeastern North Carolina with a large American Indian and African American population. Dr. Stanifer is now a Medical Instructor in the Department of Medicine at Duke University School of Medicine. Read a post by Dr. Stanifer on our blog, Kidney Today.

Susan Wong, MD (2014-2016)

Dr. Wong was awarded the American Kidney Fund-Sanofi Clinical Scientist in Nephrology Fellowship as a nephrology fellow at the University of Washington Medical Center. Dr. Wong researched the reasons some older adults do not receive dialysis as treatment for kidney failure, and the circumstances under which that decision occurs. Dr. Wong is currently Assistant Professor of Nephrology Medicine at Kidney Research Institute in Seattle, Washington.

Elaine Ku, MD, (2013-2014)

Awarded the American Kidney Fund-Amgen Clinical Scientist in Nephrology Fellowship while at the University of California, San Francisco. Dr. Ku’s project was titled Impact of Pre-End Renal Disease Management on Outcomes After Development of End-stage Renal Disease. The major goal of this study was to understand whether and how mortality risk among ESRD patients is affected by the intensity of blood pressure control during CKD. Currently, Dr. Ku is Assistant Professor at UCSF Department of Medicine – Nephrology.

Sagar Nigwekar, MD (2012-2013)

Dr. Nigwekar was awarded the American Kidney Fund-Sanofi Clinical Scientist in Nephrology Fellowship, as a research fellow at Massachusetts General Hospital. His research examined calciphylaxis and the role of vitamin D analogues and the evaluation of serum biomarker. Currently, Dr. Nigwekar is Assistant Professor of Medicine at Harvard Medical School.

Margaret Yu, MD (2012-2014)

Dr. Yu was awarded the American Kidney Fund-Sanofi Clinical Scientist in Nephrology Fellowship while she was a nephrology fellow at the University of Washington. Dr. Yu’s research examined the gender differences in chronic kidney disease prevalence, risk factors and progression in an outpatient diabetic population. Dr. Yu is currently a Clinical Assistant Professor at Stanford.

Katherine Lynch, MD (2012-2014)

Dr. Lynch was awarded the American Kidney Fund Clinical Scientist in Nephrology fellowship as a nephrology fellow at Beth Israel Deaconess Medical Center. Dr. Lynch’s research examined the clinical effectiveness of common interventions aimed at mitigating intradialytic hypotension. She is currently a nephrologist, and Instructor at Beth Israel Deaconess Medical Center in Boston.

Graham Abra, MD (2011-2013)

As an American Kidney Fund-Amgen Clinical Scholar at Stanford School of Medicine, Dr. Abra’s project focused on the design of an electronic health record-based intervention, using alerts for physicians, pharmacists and nurses, for medications in need of adjustment in patients with hospital-acquired acute kidney injuries (AKI). Pre and post-intervention response times to medication adjustment, adverse drug events, length of stay and risk-adjusted cost in patients with hospital acquired AKI, were evaluated in order to learn process improvement through electronic health record order set design, multidisciplinary committee work and intervention analysis. Dr. Abra is currently Director of Medical Clinical Affairs at Satellite Healthcare in Northern California.

Ernest Mandel, MD (2011-2013)

As an American Kidney Fund Clinical Scholar at Brigham and Women’s Hospital and Harvard Medical School’s Channing Laboratory, Dr. Mandel examined the role of diet in acid-base balance and the development and progression of chronic diseases, with a focus on developing preventive strategies to lessen their disease burden. Currently, Dr. Mandel is Associate Director at Brigham and Women’s Hospital/Massachusetts General Hospital Joint Nephrology Fellowship Program.

Jamie Green, MD (2010-2012)

As an American Kidney Fund-Genzyme Clinical Scholar from the University of Pittsburgh, Dr. Green’s study assessed the association of health literacy with dialysis treatment adherence in patients receiving in-center hemodialysis. Dr. Green is currently a Clinical Investigator at Geisinger Health in Pennsylvania.

Jenny Shen, MD (2010-2012)

As an American Kidney Fund-Amgen CSN Clinical Scholar at Stanford University, Dr. Shen’s research, titled Risks and Benefits of Heparin Use in Maintenance Hemodialysis, determined the associations among heparin dose and the risks of important clinical events. Her study also described patterns and correlates of heparin use in patients receiving maintenance hemodialysis at the facilities of a national provider of dialysis services. Dr. Shen is an Assistant Professor of Medicine at UCLA.

Delphine Tuot, MD (2010-2012)

As an American Kidney Fund-Amgen CSN Clinical Scholar at the University of California, San Francisco, Dr. Tuot’s research determined whether patient awareness of CKD is associated with greater application of evidence-based medical regimens in a nationally representative sample. Additionally, her study sought to determine concordance between physician recognition and patient awareness of CKD in clinical settings with diverse patients in the San Francisco Bay area. Currently, Dr. Tuot is as Associate Professor at UCSF School of Medicine.

Julie Wright-Nunes, MD (2009-2011)

As an American Kidney Fund-Amgen CSN Clinical Scholar at Vanderbilt University Medical Center, Dr. Wright-Nunes’ research titled, Facilitating Physician Delivered CKD Patient Education, evaluated the impact of low literacy materials used by nephrologists while delivering patient CKD education and care. Dr. Wright-Nunes is a nephrologist and Assistant Professor at the University of Michigan.

Nisha Bansal, MD (2008-2010)

As an American Kidney Fund-Genzyme Clinical Scholar at the University of California, San Francisco, Dr. Bansal’s research focused on the impact of CKD on the clinical presentation of coronary artery disease. Additionally, her study examined the role of CKD-specific risk factors and medication use on the presentation of coronary artery disease. Dr. Bansal is Assistant Professor in the Division of Nephrology at the University of Washington Medical Center, in Seattle.

Tamara Isakova, MD (2008-2010)

As an American Kidney Fund-Amgen CSN Clinical Scholar at Massachusetts General Hospital, Dr. Isakova’s research titled Postprandial Hypocalcemia in Secondary Hyperparathyroidism in Early Chronic Kidney Disease, sought to enhance understanding of postprandial calcium and parathyroid metabolism and how to normalize these in early CKD. Dr. Isakova is currently Director at the Institute for Public Health and Medicine–Center for Translational Metabolism and Health at Northwestern Medicine’s Feinberg School of Medicine.

Carmen Peralta, MD (2007-2008)

As an American Kidney Fund-Amgen Clinical Scholar at the University of California, San Francisco, Dr. Peralta's research examined the roles that individual genetic ancestry and socioeconomic status play in chronic kidney disease, and how these factors impact the progression to end stage renal disease. Dr. Peralta is an Associate Professor at UCSF School of Medicine.

Tammy Brady, MD, MHS (2006-2008)

As an American Kidney Fund-Amgen Clinical Scholar from Johns Hopkins University, Dr. Brady investigated whether an automated computerized algorithm increased the recognition of elevated blood pressures in an urban primary pediatric clinic setting.  Dr. Brady also worked to identify the modifiable risk factors associated with poor physician recognition of elevated blood pressures during well-child visits, and to determine the prevalence of hypertension in the stated population over a twelve month period. She was awarded Best Clinical Abstract at the American Society of Pediatric Nephrology annual meeting in 2007 for her work on this project.  In July 2008, Dr. Brady joined the faculty of the Johns Hopkins University School of Medicine as an Assistant Professor of Pediatrics in the Division of Nephrology. She is currently, Medical Director of the Pediatric Hypertension Program at Johns Hopkins.

Orlando Gutierrez, MD, MMSc (2006-2008)

As an American Kidney Fund-Genzyme Clinical Scholar from Massachusetts General Hospital, Dr. Gutierrez examined novel connections between disorders of phosphorus metabolism and cardiovascular disease in patients with chronic kidney disease. In addition, Dr. Gutierrez examined differences in phosphorus metabolism in healthy patients, and in those with chronic kidney disease.  Dr. Gutierrez was named the 2008 Valedictorian of the Scholars in Clinical Science Program at Harvard Medical School. Dr. Gutierrez is currently an Assistant Professor at the University of Alabama at Birmingham School of Public Health.

Jeffrey Fadrowski, MD, MHS (2005-2006)

As an American Kidney Fund-Amgen Clinical Scholar at Johns Hopkins University, Dr. Fadrowski examined the type of vascular access in a cohort of pediatric hemodialysis patients and the relationship between the type of vascular access and the frequency of infection and hospitalization. Dr. Fadrowski is an Associate Professor at Johns Hopkins University School of Medicine. He is also the recipient of NIH's K23 Mentored Patient-Oriented Research Career Development Award and the National Kidney Foundation's Young Investigator Grant Award.

Krista Lentine, MD, MS (2004-2005)

As an American Kidney Fund Clinical Scholar at Washington University School of Medicine in Missouri, Dr. Lentine explored registry data from the USRDS, OPTN and Medicare, to investigate the risk, predictors and outcomes of cardiovascular disease events after kidney transplantation. During her CSN fellowship, she completed a Master of Science in Clinical Epidemiology degree from Stanford University. Since completing her CSN fellowship, she has earned a National Institutes of Health (NIH) Loan Repayment Award for Clinical Research and a five-year Career Development (K-series) Award from the NIH National Institute of Diabetes Digestive and Kidney Diseases, for her active interests in the cardiovascular complications of kidney disease. Dr. Lentine is a tenured Associate Professor at Saint Louis University, with appointments to the Center for Outcomes Research and the Division of Nephrology.

Eric Taylor, MD (2004-2006)

As an American Kidney Fund-Genzyme Clinical Scholar at the Brigham and Women's Hospital of Massachusetts, Dr. Taylor evaluated novel risk factors for kidney stone formation. During his fellowship, he completed his Masters of Science in Epidemiology from the Harvard School of Public Health. Dr. Taylor has authored over 40 original research publications. He is a nephrologist at Maine Nephrology Associates, in Portland, Maine.

Yoshio Hall, MD (2003-2005)

As an American Kidney Fund-Amgen Clinical Scholar at the University of California, San Francisco, Dr. Hall investigated differential outcomes among Asian and Pacific Islander Americans with ESRD. During his fellowship, Dr. Hall completed the UCSF Advanced Training in Clinical Research Program. He is currently Director of the Nephrology Fellowship Training Program, as well as Clinical Associate Professor of Medicine at the Kidney Research Institute at the University of Washington in Seattle.

Karen Smirnakis, MD, PhD (2003-2005)

As an American Kidney Fund Clinical Scholar at Massachusetts General Hospital, Dr. Smirnakis’ research interests focused on the prevention of end-stage renal disease by early diagnosis and treatment of diabetes mellitus. Her project examined postpartum screening for diabetes among women with a history of gestational diabetes. Dr. Smirnakis completed a Masters of Public Health degree from the Harvard School of Public Health. She is currently Medical Director, Safety Risk and Benefit at Biogen.

Manjula Kurella Tamura, MD, MPH (2002-2004)

As an American Kidney Fund-Genzyme Clinical Scholar at the University of California San Francisco, Dr. Kurella Tamura focused on the impact of chronic kidney disease in the elderly. Her proposal focused on cognitive function in elderly patients with advanced renal failure. Dr. Kurella Tamura received a Master of Public Health degree from University of California, Berkeley. Currently, she is an Assistant Professor of Medicine in the Division of Nephrology at Stanford University and the Palo Alto Veterans Affairs Health Care System.

Jeffrey Rubel, MD (2001-2003)

As an American Kidney Fund-Amgen Clinical Scholar at Brigham and Women’s Hospital in Boston, Massachusetts, Dr. Rubel evaluated the effectiveness of established guidelines for treating and preventing coronary artery disease, and the ability of health care providers to successfully implement these strategies.  Dr. Rubel completed a Master of Public Health degree from the Harvard School of Public Health. Dr. Rubel now practices at Beverly Hospital in Massachusetts.

Holly J. Kramer, MD, MPH (2000-2002)

As an American Kidney Fund Clinical Scholar at Massachusetts General Hospital, Dr. Kramer conducted what may be the first study to investigate the effects of hormone replacement therapy on morbidity and mortality in post-menopausal women with ESRD.  Also during her CSN fellowship, Dr. Kramer completed a Master of Public Health degree from the Harvard School of Public Health. Dr. Kramer joined the faculty at Loyola Medical Center in 2002 with a joint appointment in the Department of Preventive Medicine and in the Department of Medicine, Division of Nephrology and Hypertension. Currently, Dr. Kramer is an investigator, Associate Professor and Program Director for the MPH Program at Loyola University Medical Center.

Preston S. Klassen, MD, MHS (2000-2001)

As an American Kidney Fund Clinical Scholar at Duke University, Dr. Klassen conducted an in-depth study of the relationship between blood pressure and clinical outcomes in dialysis patients.  Dr. Klassen had the unique opportunity to spend part of his fellowship at the Centers for Medicare and Medicaid Services in Baltimore, Maryland. During his fellowship, Dr. Klassen completed the requirements for a Master of Health Science degree at the Duke University Clinical Research Training Program. He was also previously on the faculty of Duke University Medical Center. Dr. Klassen is now Executive Vice President of Research and Development and Chief Medical Officer at Arena Pharmaceuticals.

Liam Casserly, MD, MSc (1999-2001) 

As an American Kidney Fund-Amgen Clinical Scholar at Boston Medical Center, Dr. Casserly conducted a study of hypertensive heart disease among ESRD patients and completed a Master of Science degree in epidemiology and biostatistics at Boston University’s School of Public Health. He is now an academic nephrologist in Ireland.

Chi-Yuan Hsu, MD, MSc (1998-2000)

As an American Kidney Fund Clinical Scholar at Massachusetts General Hospital and later at the University of California, San Francisco, Dr. Hsu completed a study of the risk factors for chronic renal insufficiency. During his fellowship he also earned a Master of Science degree in Epidemiology at the Harvard School of Public Health. Dr. Hsu became Chief of the Division of Nephrology at UCSF in 2008 and has since been promoted to Professor. 

Rulan S. Parekh, MD, MSc (1997-1999)

As an American Kidney Fund-Amgen Clinical Scholar at the University of Michigan in Ann Arbor, Dr. Parekh conducted a study of cardiovascular mortality in children with ESRD. She also completed a Master of Public Health degree, with a concentration in biostatistics and clinical research. Dr. Parekh is Associate Chief, Clinical Research at Hospital for Sick Children Research Institute and Professor of Pediatrics and Medicine at Hospital for Sick Children, University Health Network and University of Toronto.

Lynda Szczech, MD, MSCE (1996-1997) 

As an American Kidney Fund Clinical Scholar at the University of Pennsylvania School of Medicine, Dr. Szczech’s project was titled, The Impact of Post-Transplant Antibody Therapy on Kidney Transplant Survival. She has published several clinical articles and has most recently served as Executive Medical Director at FibroGen, Inc.

Ravi Thadhani, MD, MPH (1995-1998)

As an American Kidney Fund-Amgen Clinical Scholar at Massachusetts General Hospital, Dr. Thadhani conducted research on pregnancy-related kidney disease and earned a Master in Public Health degree. Dr. Thadhani is currently a Professor of Medicine at Harvard Medical School and Chief of the Division of Nephrology at Massachusetts General Hospital in Boston. As of September, 2017, Dr. Thadhani was appointed as Vice Dean, Research and Education at Cedars-Sinai in Los Angeles.

David M. Kates, MD, MHSc (1994-1996)

As an American Kidney Fund Clinical Fellow at the University of Washington, School of Medicine in Seattle, Dr. Kates studied cardiovascular disease in ESRD patients. Formally, Dr. Kates was the Director of the Renal Program at Kelowna General Hospital, and the Director of the Regional Transplant Program. In 1996, Dr. Kates founded David Kates Medical Services Inc.

Glenn M. Chertow, MD, MPH (1993-1995)

As an American Kidney Fund-Amgen Clinical Scholar at Brigham and Women’s Hospital in Boston, Dr. Chertow conducted research on nutrition and kidney disease and earned a Master’s Degree in Clinical Epidemiology at the Harvard School of Public Health. Dr. Chertow is currently Professor of Medicine and Chief, Division of Nephrology at Stanford University School of Medicine. Prior to joining the faculty at Stanford, Dr. Chertow served with distinction on the faculties at Brigham and Women’s Hospital and Harvard Medical School (1995-98) and the University of California San Francisco (1998-2007).  Dr. Chertow has established a successful career as a clinical investigator and continues to maintain a productive research program focused on improving care for persons with acute and chronic kidney disease.  He was Vice Chair and member of two workgroups for the Kidney Disease Quality Outcomes Initiative (K/DOQI) and Associate Editor of the Journal of the American Society of Nephrology.

David A. Roth, MD, MSCE (1992-1994)

As an American Kidney Fund Clinical Scholar at the University of Pennsylvania, Dr. Roth conducted research on renal disease among African Americans and earned a Master of Science in Clinical Epidemiology degree. Dr. Roth is currently Vice President, Medicines Development Leader at GlaxoSmithKline Pharmaceuticals in Philadelphia, PA.

Rebecca L. Hegeman, MD, MPH (1991-1993)

As an American Kidney Fund Clinical Scholar, Dr. Hegeman researched renal failure in transplantation as she completed classes required for a Master of Public Health. Dr. Hegeman is currently Clinical Professor and Interim Director at the University of Iowa College Of Medicine, Nephrology Division in Iowa City. 

Gary C. Curhan, MD, ScD (1990-1992) 

As a Kidney Fund Clinical Scholar, Dr. Curhan conducted studies focusing on kidney stones. This research has served as the foundation for the ground-breaking kidney stone research that Dr. Curhan currently pursues at Brigham and Women’s Hospital in Boston, Massachusetts.  Dr. Curhan is a Professor of Medicine at Harvard Medical School, as well as Editor-in-Chief of a leading nephrology journal, the Clinical Journal of the American Society of Nephrology.

Rhonda B. Rubin, MD (1989-1991)

As an American Kidney Fund Clinical Scholar at Montefiore Medical Center in Bronx, NY, Dr. Rubin studied the impact and special needs of AIDS and HIV infected patients in dialysis units. She has also co-authored numerous research articles. Dr. Rubin currently works at Westchester Health medical group in Valhalla, NY.

Stephen R. Smith, MD, MHS (1989-1991)

As an American Kidney Fund Clinical Scholar at Duke University School of Medicine, Dr. Smith studied the effects of potassium chloride supplementation on blood pressure among elderly patients. Dr. Smith joined the Duke University faculty and became Medical Director of the Kidney Transplant Program in 1993 and Training Program Director for the Nephrology Fellowship in 2005. Currently, Dr. Smith is Clinical Affairs, Vice Chief at Duke University School of Medicine.  

Maria E. Ferris, MD, MPH, PhD (1989-1991)

As an American Kidney Fund Clinical Scholar at the University of California, San Diego, Dr. Ferris studied congenital renal and urinary tract conditions. Dr. Ferris is Founder and Director of the UNC Transition Program, as well as an Associate Professor of Medicine and Pediatrics at the University of North Carolina at Chapel Hill.